UPC logo
UPC NASDAQ CN

Universe Pharmaceuticals Inc - Class A Ordinary Shares

Healthcare · Pharmaceuticals Website · IPO Mar 2021
$3.16
▲ +$0.43 (+15.75%)
Vol 9K
9
Quality Score
ok
Mkt Cap
$2.1M
P/E
2.0
ROE
2.2%
Margin
-35.9%
D/E
14.01
Beta
1.53
52W
$3–$28

Price Chart

Fundamentals Trend

Metric 2025-03-31 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%
P/E (TTM) 1.93 1.85 2.28 2.44 1.85 1.97
Net Margin -35.9% -35.9% -35.9% -35.9% -35.9% -35.9%
Gross Margin 34.6% 34.6% 34.6% 34.6% 34.6% 34.6%
D/E Ratio 14.01 14.01 14.01 14.01 14.01 14.01
Current Ratio 2.78 2.78 2.78 2.78 2.78 2.78

Key Ratios

ROA (TTM)
1.5%
P/S (TTM)
0.23
P/B
0.1
EPS (TTM)
$191.57
CF/Share
$-2.26
Rev Growth 3Y
+1.7%
52W High
$28.00
52W Low
$2.51
$2.51 52-Week Range $28.00

How does UPC compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

UPC valuation vs Pharmaceuticals peers

P/E ratio
2.0
91% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
0.2
95% below peers (5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
0.1
94% below peers (2.1)
vs Peers
vs Industry
Undervalued
Div yield
0% below peers (2.0%)
vs Peers
vs Industry
Low yield

UPC profitability vs Pharmaceuticals peers

ROE
2.2%
104% above peers (-54.3%)
vs Peers
vs Industry
Top tier
Net margin
-35.9%
24% above peers (-47.4%)
vs Peers
vs Industry
Weak
Gross margin
34.6%
49% below peers (68.3%)
vs Peers
vs Industry
Weak
ROA
1.5%
104% above peers (-37.4%)
vs Peers
vs Industry
Top tier

UPC financial health vs Pharmaceuticals peers

D/E ratio
14.0
810% above peers (1.5)
vs Peers
vs Industry
Above avg
Current ratio
2.8
17% below peers (3.4)
vs Peers
vs Industry
Below avg
Beta
1.5
63% above peers (0.9)
vs Peers
vs Industry
More volatile

UPC fundamentals radar

UPC Peer median Industry

UPC profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

UPC vs peers: key metrics